Xiao-li E. Wei
State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Erratum: Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells: Erratum.
Journal: Theranostics
Published: May 14, 2025
Erratum: Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression: Erratum.
Journal: Theranostics
Published: February 03, 2025
Erratum: Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic Implications: Erratum.
Journal: Theranostics
Published: February 03, 2025
The first-in-class bispecific antibody IBI318 (LY3434172) targeting PD-1 and PD-L1 in patients with advanced tumors: a phase Ia/Ib study.
Journal: Journal of hematology & oncology
Published: October 17, 2024
Claudin 18.2-targeting antibody-drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial.
Journal: The Lancet. Oncology
Published: August 14, 2024
First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumors.
Journal: Cell reports. Medicine
Published: January 21, 2024
Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma.
Journal: Cell reports. Medicine
Published: July 16, 2022
Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients.
Journal: Frontiers in immunology
Published: June 19, 2022
First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumors.
Journal: Nature communications
Published: April 30, 2022
Association of Plasma Epstein-Barr Virus DNA With Outcomes for Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Anti-Programmed Cell Death 1 Immunotherapy.
Journal: JAMA network open
Published: March 01, 2022
Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature.
Journal: Clinical Medicine Insights. Oncology
Published: October 25, 2021
Last Updated: 09/26/2026